Happy Thanksgiving everyone. Here are the stories that have piqued our interest today - Foodborne illness, rare Diseaes in Canada, Keytruda, Dravet syndrome
It is Thanksgiving and that usually means a smorgasbord of deliciously smoked turkey, fluffy yams and tangy cranberry sauce.
Lysogene, Eli Lily, SAGE, Insmed, Biomarin, Sarepta, and Merck are in the headlines.
Pachyonychia congenita (PC) is a rare genetic skin disorder, inherited in an autosomal dominant manner.
Mixed Results from the FDA Advisory Committee meeting for Drisapersen
the FDA approved Portrazza (necitumumab) in combination with gemcitabine and cisplatin for the first-line treatment of people with metastatic squamous non-small cell lung cancer (NSCLC).
The FDA approved a new indication for Emergent Biosolution’s BioThrax (Anthrax Vaccine Adsorbed) to prevent anthrax disease following suspected or confirmed exposure to Bacillus anthracis.